|
CN105198965A
|
|
VEGFR2 blocker polypeptide and application thereof
|
|
CN105193825A
|
|
Application of sarsasapogenin 3-hydroxyl formyl ester to preparation of drug for treating cervicitis
|
|
CN105193780A
|
|
Application of gymnothol A in preparation of anti-VVC (vulvovaginal candidiasis) drug
|
|
CN105193834A
|
|
Application of 4(R)-panax japonicus glucoside R1 to preparation of active drug for treating insulin resistance
|
|
CN105111294A
|
|
Chinese yam peptide and application thereof
|
|
CN105111284A
|
|
Tumor necrosis factor inhibitory polypeptide and application thereof
|
|
CN105175504A
|
|
Von Willebrand factor inhibition polypeptide and application thereof
|
|
CN105175503A
|
|
Factor VIII inhibitory polypeptide and application thereof
|
|
CN105111293A
|
|
Amorphophallus konjac peptide and application thereof
|
|
CN105111292A
|
|
Taro mucoprotein peptide and application thereof
|
|
CN105175505A
|
|
Leptin excitation polypeptide and application thereof
|
|
CN105131088A
|
|
Yacon protein polypeptide and applications
|
|
CN105175513A
|
|
Polyethylene glycol modified GLP-1 receptor agonist peptide and application thereof
|
|
CN105175514A
|
|
Polyethylene glycol modified insulin-like polypeptide and application thereof
|
|
CN105061566A
|
|
Pseudoinsulin polypeptide and application thereof
|
|
CN105061583A
|
|
Peripheral interleukin 35 polypeptide and application thereof
|
|
CN105061600A
|
|
Rheumatoid factor IgA inhibitory polypeptide and application thereof
|
|
CN105061565A
|
|
Polypeptide inhibiting interferon regulation factor 5 and application thereof
|
|
CN105017388A
|
|
NOD1 protein inhibiting polypeptide and application thereof
|
|
CN105017389A
|
|
Toll-like receptor 5 inhibiting polypeptide and application thereof
|
